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1. Introduction 
In the past few years, oligomers of -aminoacids have become a 
subject of considerable interest.
1-5
  These unnatural peptides 
possess a high resistance to peptidase-catalyzed hydrolysis
6-7
 and 
often present discrete and predictable folding propensities 
(foldamers).
8-11
 Usually, -peptides with cyclic -aminoacid 
residues display a higher intrinsic tendency to adopt a regular 
secondary structure (helix, sheet and turn) than acyclic residues 
do.
12-15
 However, up to now, most of these results have been 
obtained in organic solvents, because cyclic -aminoacids and 
the resulting peptides often show a limited solubility in water. 
Only some examples of -peptides with a helical conformation in 
aqueous solution have been obtained by modification of the 
cyclic framework with appropriate hydrophilic substituents.
12
  
Cyclic--aminoacids have also been exploited as scaffolds in the 
synthesis of glycomimetic compounds. Our group demonstrated 
the use of (1S,2R)-2-amino-cyclohexanecarboxylic acid as a 
scaffold to prepare a mimic of Lewis-x trisaccharide where 
sugars or sugar-like fragments are connected avoiding glycosidic 
bonds.
16
 These modifications of the oligosaccharide structure are 
used to improve metabolic stability and activity and to simplify 
the synthesis of the final glycomimetic compounds.  
Introduction of additional substituents on cyclic -aminoacid 
frameworks has also been actively sought after.
17-18
 Beside 
improving (water) solubility, additional substituents can be 
exploited to allow conjugation of -peptides or other -
aminoacid-containing molecules to additional elements. For 
instance, -peptides could be connected to biologically relevant 
fragments, such as oligosaccharides, which are often essential for 
full biological activity of natural -peptides. In our glycomimetic 
research program, functionalized cyclic -aminoacids are 
required to achieve polyvalent presentation of derived 
oligosaccharide mimics on dendrimers and other polymeric 
scaffolds, a topic of current high interest in the field of 
carbohydrate mimicry.
19, 20
  
Herein, we report the practical synthesis of enantiomerically pure 
and orthogonally protected derivatives of trans- and cis-2-
aminocyclohexanecarboxylic acids (ACHC) 2 and 3, 
functionalized in the cyclohexane ring with a hydroxy group, to 
increase solubility in water, and with a functional 2-azidoethyl 
linker to be used as a conjugation handle. Azides give acess to 
various efficient approaches for bioconjugation,
21
 including  the 
1,3-dipolar cycloaddition known as the ―click reaction‖.
22
 
2. Results and discussion 
Compounds 2 and 3 were prepared in a few synthetic steps from 
commercially available tetrahydrophthalic anhydride 1 through 
the known protected -cyclohexenecarboxylic acids 4
23
 and 6.
24
 
Key to our strategy was the stereoselective synthesis of epoxides 
5 and 7 and their regio- and stereoselective opening by metal-
catalyzed alcoholysis (Scheme 1). 
The synthesis of 2 (Scheme 2) began with Bölm 
desymmetrization
25-26
 of 1 in the presence of quinidine. The 
resulting cis-hemi-ester 8 (93% e.e.) was epimerized to the trans- 
isomer 9 using potassium t-amylate at -15ºC, as described by Yue 
et al,
 23
 to afford a 5.5:1 trans : cis mixture. Finally, the trans-
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2 
2 
isomer 9 was selectively crystallized (Et2O-Hexane) as its (R)-
-methylbenzylamine salt 10, which improved the trans : cis 
ratio to 11:1, and the trans-hemi-ester 9 was liberated from salt 
10 by treatment with HCl (1N) and extracted into AcOEt. The 
entire sequence could be performed without any chromatographic 
purifications and yielded 9 with 80% overall yields from 1. 
Curtius rearrangement of 9 and conversion of the resulting 
isocyanate to a t-butylcarbamate via reaction with t-butyl alcohol 
and CuCl gave the protected -aminocyclohexenecarboxylic acid 
derivative 4 (65%).
24-27
 Remaining traces of the 1,2-cis isomer 
were chromatographically removed at this stage. MCPBA 
oxidation of 4 proceeded to afford the (1R,2R,4S,5R) epoxide 5. 
A single isomer was isolated, featuring the epoxide ring cis to the 
carbamate moiety, as expected
28
 and previously described for the 
corresponding ethyl ester.
17
 No trace of the 4R,5S isomer could 
be identified by 
1
H-NMR spectroscopy. 
Regioselective alcoholysis of  5 occurred uneventfully, using 
20% Cu(OTf)2
 
in chloroethanol,
29 
 and afforded 11 in quantitative 
yield. The position of substituents and the relative configuration 
of the stereocenters in 11 could be unequivocally established by 
NMR spectroscopic analysis and are those expected by trans-
diaxial opening of a single chair-like conformation of 5, featuring 
carbomethoxy and amino groups in a trans-diequatorial 
disposition. Protection of the hydroxyl group is not necessary at 
this point, but it was performed (TBDMSOTf, lutidine, 97%) for 
the sake of obtaining the final compound in a fully orthogonally 
protected form. Finally, treatment of 12 with NaN3 afforded the 
required functionalized (1R,2Rtrans-aminoacid synthon 2 in 
quantitative yield (Scheme 2).  
 
 
Scheme 1. General strategy for the synthesis of functionalized cyclic -aminoacids  2 and 3 
 
 
Scheme 2. Stereoselective synthesis of 2 
For the synthesis of the (1S,2Rcis isomer 3 (Scheme 3), Curtius 
rearrangement of hemi-ester 8 under the conditions described 
above afforded the protected cis amino acid 6,
24 
which was 
oxidized with MCPBA to give epoxide 4 in 63% yield, as a 
single isomer. The structure of epoxide 4 could not be fully 
determined by NMR spectroscopic analysis, but the formation of 
a single isomer likely results from H-bonding interaction of 
MCPBA with the carbamate functionality.
28
 Thus, the structure 
of 7 was tentatively attributed, and later confirmed upon analysis 
of the ring-opening products.   
COOH
COOMe
NHBoc
COOMe
NHBoc
COOMe
O
1. DPPA, Et3N
Toluene, reflux
2. tert-BuOH, CuCl
Toluene, 80ºC
65%
MCPBA
CH2Cl2
63%
8
7
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Scheme 3.  Synthesis of epoxide 7 
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3 
3 
Alcoholysis of 7 is complicated by the conformational flexibility 
of the 6-membered ring, which can attain two conformations of 
similar energy, A  and B (Figure 1). Based on the trans-diaxial 
requirement of epoxide opening reactions, these conformers are 
expected to react with opposite regioselectivity: conformer A 
should undergo C5-opening yielding the chloroethyl ether 13 and 
conformer B should react preferentially at C4 affording ether 14 
(Figure 1 and Scheme 4). Molecular mechanics (MM2*) 
calculations predict that the C5-opening product would exist as 
an equilibrium mixture of two chair conformations 13-c1 and 13-
c2. On the contrary, the C4-opening compound 14 is expected to 
adopt mainly conformation 14-c2, featuring the carbomethoxy 
group in equatorial position. Although somewhat unexpectedly 
on the basis of A parameters,
30
 a marked conformational bias for 
equatorial carbalkoxy group over equatorial N-carbamate was 
previously observed in cis-2-aminocarbalkoxy-
cyclohexanecarboxylic acid esters.
16 
 
 
Figure 1. Conformations A and B of 7, as calculated by molecular mechanics 
(MM2*), their preferred opening pathways and conformational equilibria of 
the C5- and C4-opening products 13 and 14. 
The alcoholysis of epoxides can be catalyzed by a number of 
Lewis acids and some of these were examined in order to achieve 
maximum yield and regioselectivity in the 2-chloroethanol 
opening reaction of 7 (Table). We focused our effort on 
optimizing the C-4 opening process, since it is predicted to afford 
a product (14) with reduced conformational freedom.   
 
NHBoc
COOMe
O
Cu(OTf)2
Cl
OH
7
NHBoc
COOMe
NHBoc
COOMeHO
HO
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Scheme 4. Alcoholysis of 7 
No reaction was obtained without a catalyst or using BF3.Et2O as 
the promoter (entry 1). In contrast, good reactivity was obtained 
in chloroethanol at room temperature using various metal triflates 
(entries 2-6), which are known catalysts for alcoholysis of 
epoxides.
29
 The reaction showed little regioselectivity, however 
the two ether products proved easily separable by flash 
chromatography and could be fully characterized, based on the 
different 
13
C chemical shifts of C4 and C5, which are found, 
respectively, at 71.1 and 79.8 in 13 and 79.3 and 70.2 in 14. This 
set of experiments allowed to select Cu(OTf)2 as the promoter 
of choice for the synthesis of 14.   The selectivity appears to 
slightly increase by increasing the amount of catalyst from 5% to 
20%. The best results were achieved using 20% Cu(OTf)2 at 
40ºC (Table 1, entry 7): under these conditions, the global yield 
of chloroethyl ethers was almost quantitative, which gave 14 in a 
satisfactory 74% yields after chromatography. No further 
selectivity increase was observed with higher catalyst loading. 
1
H NMR spectroscopic analysis of the chloroethylether products 
allowed to validate the computational predictions concerning the 
conformational behavior of these cyclic -aminoacids. 
Diagnostic data were obtained from the coupling constants of 
proton H1, which appeared as a quartet with J = 4.4 Hz in 13 and 
as a doublet of triplets with J = 9.3 Hz and 4.1 Hz in 14. This is 
consistent with the prediction that 13 exists as a pair of 
interconverting chairs, while 14 populates one main chair 
conformation with the carbomethoxy group in equatorial 
position.  
Table 1. Alcoholysis of 7 in chloroethanola 
Entry Catalyst % cat T (ºC) 14/13 ratiob 14 (%)c 
1 BF3.Et2O 1 eq 25 - No rxn 
2 La(OTf)3 10 25 1.2 / 1 Not isol. 
3 Zn(OTf)2 10 25 1 / 1.3 Not isol. 
4 Cu(OTf)2 5 25 1.4 / 1 55 
5 Cu(OTf)2 10 25 1.5 / 1 60 
6 Cu(OTf)2 20 25 2.2 / 1 65 
7 Cu(OTf)2 20 40ºC 2.3 / 1 74 
a. Reactions were performed in chloroethanol,  for 3 h at the temperature 
indicated.  b. by 1H-NMR spectroscopy of crude reaction mixtures  c. 
isolated yield   
As for the 1,2-trans isomer, the free hydroxyl group of 14 was 
protected as ITS silyl ether (Scheme 5, 95% yield) and, finally, 
chloro-azide exchange in the linker was achieved using excess 
NaN3 in DMF at 50ºC, to obtain 3 in quantitative yield. The same 
sequence on the minor isomer 13 afforded in similar yield the 
regioisomeric derivative 16 (Scheme 5). 
3. Conclusions 
In conclusion, in this work we have established a practical 
synthesis of enantiomerically pure 1,2-trans and 1,2-cis 2-
aminocyclohexanecarboxylic acid (ACHC) derivates 2 and 3 
featuring a hydroxyl group and a versatile 2-azidoethyl linker. 
The regioisomeric 1,2-cis compound 16 was also prepared, as a 
minor isomer of 3. All compounds were prepared in the 2R series 
using Bölm desymmetrization of tetrahydrophtalic anhydride 1 
with quinidine. The enantiomeric 2S series can be prepared using 
quinine in the initial step.
25
 We have also shown that both 2 and 3 
are conformationally well-defined structures, populating a single 
(2) or a major (3) chair conformation. The conformational 
equilibrium of 3 appears dominated by an apparent bias of the 
carbomethoxy group to occupy the equatorial position 
preferentially over the N-carbamate group.
16
 All the compounds 
prepared are orthogonally protected and can be used in 
combination with other ACHC derivatives, as building blocks to 
construct -peptides with improved water solubility. The azido 
group can also be used as a tether to conjugate different residues 
to the -peptides like in natural proteins or peptides composed of 
-aminoacids. 
4. Experimental section  
4.1 Material and methods 
C5-opening 
C4-opening 
C5-opening
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4 
4 
Solvents were dried by standard procedures: dichloromethane, 
methanol, N,N-diisopropylethylamine and triethylamine were 
dried with calcium hydride; chloroform and pyridine were dried 
with activated molecular sieves. Reactions requiring anhydrous 
conditions were performed under nitrogen. 
1
H and 
13
C NMR 
spectra were recorded at 400 MHz with a Bruker AVANCE-400 
instrument. Chemical shifts (δ) for the 
1
H and 
13
C NMR spectra 
are expressed in ppm relative to internal Me4Si as standard. 
Signal multiplicities are abbreviated as follows: s, singlet; br. s, 
broad singlet; d, doublet; t, triplet; q, quartet; m, multiplet. Mass 
spectra were obtained with a Bruker ion-trap Esquire 3000 (ESI 
ionization) or Autospec Fission spectrometer (FAB ionization) 
and FT-ICR Mass Spectrometer APEX II & Xmass 4.7 Magnet 
software (Bruker Daltonics). Thin-layer chromatography (TLC) 
was carried out on precoated Merck F254 silica gel plates. Flash 
chromatography (FC) was carried out on Macherey–Nagel silica 
gel 60 (230–400 mesh). 
 
4.2 Methyl (1R,2R)-2-(N-tert-butoxycarbonylamine)cyclohex-4-
enecarboxylate (4) 
 A solution of 9
23
 (600 mg, 3.26 mmol) in dry Toluene (6 mL) 
was treated with Et3N (550 L, 2.20 mmol) and DPPA (770 L, 
3.42 mmol). The solution was heated slowly at 80ºC, kept at this 
temperature until evolution N2 ceased, and refluxed for 3 hours. 
Then, the solution was cooled at room temperature and tert-
BuOH (1.67 mL, 16.30 mmol) and CuCl (15 mg, 0.13 mmol) 
were added and the reaction was stirred in reflux overnight. 
Then, the reaction mixture was cooled and room temperature and 
washed with NaHCO3 sat. (2x 50 mL). The aqueous phases were 
extrated with Et2O (50 mL).  The combined organic phases were 
dried over Na2SO4 and 
 
 
 
Scheme 5. Synthesis of the 1,2-cis functionalized -aminoacids.
 
concentrated under reduce pressure. The residue was purified by 
flash silica gel column chromathography using as eluent 
(Hexane-AcOEt, 7:1) to obtain 4 (541 mg, 65%) as a transparent 
oil. []D  (c. 1.00, CH2Cl2): -26.6; 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) 5.71-5.52 (m, 2H, H4, H5), 4.61 (bs, 1H, NHBoc), 4.02(bs, 
1H, H2), 3.68 (s, 1H, COOMe), 2.68 (dd, 1H, J 14.3, 8.3 Hz, H1), 
2.56-2.40 (m, 2H, H3, H6), 2.33-2.23 (m, 1H, H6’), 2.00-1.90 (m, 
1H, H3’), 1.43 (s, 9H, CH3Boc); 
13
C NMR (100 MHz, CDCl3) δ 
(ppm) 174.0 (C=O), 155.0 (C=O), 125.0 (C3 or C4), 124.2 (C3 or 
C4), 51.9(COOMe), 47.25 (C2), 44.7 (C1), 31.2 (C3), 28.3 
(CH3Boc), 26.6 (C6); ESI-MS for C13H21NO5 Calc.  M+  255.1  
Exp. 278.3 (M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 278.13623 
C13H21NO4Na requires 278.13628 
4.3 Methyl (1R,2R,4S,5R)-2-(N-tert-butoxycarbonylamine)-4,5-
epoxycyclohexanecarboxylate (5)   
To a solution of 4 (170 mg, 0.67 mmol) in dry CH2Cl2 (3 mL) 
was added MCPBA (160 mg, 0.94 mmol) at 0ºC. Then, the 
reaction mixture was warmed until room temperature and stirred 
for 3 hours. The reaction was monitored by TLC (Hex-AcOEt, 
2:1). The solution was diluted with CH2Cl2 (20 mL), washed with 
NaHCO3 sat. (3 x 20 mL), dried over Na2SO4 anh. and 
concentrated under reduce pressure. The residue was purified by 
flash silica gel column chromathography using as eluent 
(Hexane-AcOEt, 5:1) to obtain 5 (140 mg, 77%) as a white solid. 
[]D  (c. 1.05, CHCl3): -35.5; 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) 5.11 (d, 1H, J 6.6 Hz, NHBoc) 4.03 (bs, 1H, H2), 3.69 (s, 
3H, OCH3), 3.27 (t, 1H, J 3.6 Hz, H5), 3.18 (t, 1H, J 3.1 Hz, H4), 
2.65 (q, 1H, J 5.9 Hz, H1), 2.35 (td, 1H, J 15.7, 4.0 Hz, H6eq), 
2.26-2.14 (m, 2H, H3eq, H6ax), 1.92 (dd, 1H, J 15.7, 5.7 Hz, H3ax), 
1.43 (s, 9H, CH3Boc); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 173.6 
(C=O), 154.9 (C=O),  52.0 (CH3O), 51.7 (C4), 51.1 (C5), 45.9 
(C2), 41.2 (C1), 28.5 (C3), 28.3 (CH3Boc), 23.8 (C6); ESI-MS for 
C13H21NO5 Calc.  M
+
  271.1  Exp. 270.9 M+ & 294.2 (M+Na)
+
; 
HRMS (ESI): (M+Na)
+
, found 294.13142 C13H21NO5Na requires 
294.13119 
4.4 Methyl (1R,2R,4R,5R)-2-(N-tert-butoxycarbonylamine)-4-(2-
chloroethoxy)-5-hydroxycyclohexanecarboxylate (11) 
To a solution of 5 (130 mg, 0.48 mmol) in 2-chloroethanol (2 
mL) was added a catalytic amount of Cu(OTf)2 (40 mg, 0.01 
mmol) and the solution was stirred at room temperature under N2 
atmosphere for 3 hours. The reaction was monitored by TLC 
(Hex-AcOEt, 2:1).  A solution of NH4Cl:NH3 aq (1:1) (30 mL) 
was added to the reaction mixture. Then, the solution was 
extracted with AcOEt (2 x 30 mL). The organic phases were 
dried over Na2SO4 anh., and the solvent was eliminated in vacuo 
to obtain 11 (160 mg, 95%) without further purification as a 
transparent oil.
 
[]D  (c. 0.4, CHCl3): -16.7; 
1
H NMR (400 MHz, 
CDCl3) δ (ppm) 4.52 (bs, 1H, NHBoc) 3.99 (m, 1H, H2), 3.86-3.76 
(m, 2H, CH2O, H5),  3.62 (s, 3H, OCH3), 3.65-3.53 (m, 3H, 
CH2O, CH2Cl), 3.44-3.38 (dt, 1H, H4), 2.70 (bdt, 1H, J 8.8, 4.1 
Hz, H1), 2.24-2.12 (m, 1H, H6), 1.97-1.66 (m, 3H, 2H3, H6’), 1.36 
(s, 9H, CH3Boc); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 173.6 
(C=O), 154.9 (C=O), 78.4 (C4), 69.3 (CH2O), 67.4 (C5), 52.0 
(OCH3), 43.6 (C1), 43.2 (CH2Cl), 31.1 (C3), 30.0 (C6), 28.3 
(CH3Boc); ESI-MS for C15H26ClNO6 Calc.  M
+  
351.1
 
Exp. 374.2 
(M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 374.13380 
C15H26NO6ClNa requires 374.13409 
4.5 Methyl (1R,2R,4R,5R)-2-(N-tert-butoxycarbonylamine)-4-(2-
chloroethoxy)-5-(tert-butyldimethylsilanyloxy)cyclohexane 
carboxylate  (12)  
To a solution of 11 (43 mg, 0.122 mmol) and 2,6-lutidine (28 
L, 0.245 mmol) in CH2Cl2 (300 L) was added TBDMSOTf (42 
L, 0.183 mmol) and the solution was stirred at room 
temperature under N2 atmosphere for 3 hours. Then, H2O (5 mL) 
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5 
5 
was added to the reaction. The reaction mixture was extrated with 
AcOEt (15 mL). The organic phase was dried over Na2SO4 anh., 
and the solvent was eliminated in vacuo. The residue was 
purified by flash silica gel column chromathography using as 
eluent (Hexane-AcOEt, 11:1) to obtain 12 (58 mg, 97%) as a 
transparent oil. []D  (c. 0.95, CHCl3): -8.2; 
1
H NMR (400 MHz, 
CDCl3) δ (ppm) 4.47 (bs, 1H, NHBoc), 3.95 (bs, 1H, H2), 3.92-
3.80 (m, 2H, CH2O, H5), 3.69 (s, 3H, OCH3), 3.69-3.59 (m, 3H, 
CH2O, CH2Cl), 3.47-3.42 (m, 1H, H4), 2.61 (dt, 1H,  J 11.9, 3.6 
Hz, H1), 2.16-2.11 (m, H, H6), 2.07 (td, 1H, J 13.5, 3.7 Hz, H3), 
1.66 (td, 1H, J 14.1, 3.5 Hz, H6), 1.63-1.55 (m, 1H, H3), 1.37 (s, 
9H, CH3Boc), 0.83 (s, 9H, SiC(CH3)3 tert-Bu), 0.01 (s, 3H, SiCH3), 
0.00 (s, 3H, SiCH3); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 174.2 
(C=O), 154.9 (C=O), 78.2 (C4), 69.2 (CH2O), 66.7 (C5),  51.9 
(CH3O), 45.5 (C2), 44.1 (C1), 43.2 (CH2Cl), 31.3 (C6 or C3), 30.9 
(C6 or C3), 28.4 (CH3Boc), 25.7 (SiC(CH3)3), -4.9 (SiCH3), -5.0 
(SiCH3); ESI-MS for C21H40ClNO6Si Calc.  M
+  
465.2
 
Exp. 488.4 
(M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 488.22031 
C21H40NO6ClSiNa requires 294.22056 
4.6 Methyl (1R,2R,4R,5R)-4-(2-aminoethoxy)-2-(N-tert-
butoxycarbonylamine)-5-(tert-butyldimethylsilanyloxy) 
cyclohexancarboxylate (2)  
To a solution of 12 (34 mg, 0.073 mmol) in DMF (1 mL) were 
added NaN3 (38 mg, 0.58 mmol) and a catalytic amount of I2, the 
reaction was stirred for 72 hours at 50ºC. Then, the solution was 
diluted in CH2Cl2 (10 mL), washed with water (3 x 10 mL) and 
dried over Na2SO4 anh. The residue was purified by flash 
chromathography using as eluent (Hex-AcOEt, 8:1) to yield 2 (35 
mg, quant.) as an transparent oil.
 
[]D  (c. 1.25, CHCl3): -11.4; 
1
H 
NMR (400 MHz, CDCl3) δ (ppm) 4.46 (bs, 1H, NH), 4.00-3.88 
(m, 1H, H2), 3.88 (dd, 1H, J 6.0, 3.3 Hz, H5), 3.88-3.78 (m, 1H, 
CH2O), 3.67 (s, 3H, OCH3), 3.60-3.51 (m, 1H, CH2O), 3.48-3.38 
(m, 2H, H4, CH2N3), 3.33-3.23 (m, 1H, CH2N3), 2.60 (dt, 1H,  J 
12.2, 3.5 Hz, H1), 2.17-2.05 (m, 2H, H3, H6), 1.76 (td, 1H, J 13.4, 
3.3 Hz, H6), 1.67-1.56 (m, 1H, H3), 1.42 (s, 9H, CH3Boc), 0.88 (s, 
9H, SiC(CH3)3), 0.06 & 0.05 (2s, 6H, SiCH3); 
13
C NMR (100 
MHz, CDCl3) δ (ppm) 174.2 (C=O), 154.9 (C=O), 78.2 (C4), 68.2 
(CH2O), 66.8 (C5),  51.9 (CH3O), 50.9 (CH2N3), 46.5 (C2), 44.1 
(C1), 30.9 (C6, C3), 28.4 (CH3Boc), 25.8 (SiC(CH3)3), -4.8 (SiCH3), 
-5.0 (SiCH3); ESI-MS for C21H40N4O6Si Calc.  M
+  
472.3
 
Exp. 
495.4 (M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 495.26080 
C21H40N4O6SiNa requires 495.26093 
4.7 Methyl (1S,2R,4S,5R)-2-(N-tert-butoxycarbonylamine)-4,5-
epoxycyclohexanecarboxylate (7)   
To a solution of 6 (400 mg, 1.57 mmol) in dry CH2Cl2 (4 mL) 
was added MCPBA (377 mg, 2.20 mmol) and the solution was 
stirred at room temperature for 3 hours. The reaction was 
monitored by TLC (Hex-AcOEt, 2:1). Then, the solution was 
diluted with CH2Cl2 (40 mL), washed with NaHCO3 sat. solution 
(3 x 45 mL), dried over Na2SO4 anh. and concentrated under 
reduce pressure. The residue was purified by flash silica gel 
column chromathography using as eluent (Hexane-AcOEt, 4:1) 
to obtain 7 (265 mg, 63%) as a transparent oil. []D  (c. 0.51, 
CHCl3): +25.9; 
1
H NMR (400 MHz, CDCl3) δ (ppm) 4.53 (d, 1H, 
J 10.1 Hz, NHBoc) 4.07 (dtd, 1H, J 9.9, 6.6, 3.3 Hz, H2), 3.72 (s, 
3H, OCH3), 3.23-3.19 (m, 2H, H4, H5), 2.65 (dd, 1H, J 15.6, 7.6 
Hz, H6), 2.53-2.48 (m, 1H, H1), 2.23-2.19 (m, 2H, 2H3), 2.11 
(ddd, 1H, J 15.6, 6.1 & 3.2 Hz, H6), 1.44 (s, 9H, CH3Boc); 
13
C 
NMR (100 MHz, CDCl3) δ (ppm) 52.5 (CH3O), 52.3 (C4 o C5), 
51.6 (C4 o C5), 46.0 (C2), 41.0 (C1), 30.4, 29.7 (C3), 29.0 
(CH3Boc), 25.2 (C6); ESI-MS for C13H21NO5 Calc.  M+  271.1  
Exp. 270.9 M
+
 & 271.9 (M+H)
+
; HRMS (ESI): (M+Na)
+
, found 
294.13148 C13H21NO5Na requires 294.13119 
4.8 Methyl (1S,2R,4S,SR)-2-(N-tert-butoxycarbonylamino)-4-(2-
chloroethoxy)-5-hydroxycyclohexanecarboxylate (13) and Methyl 
(1S,2R,4R,5R)-2-(N-tert-butoxycarbonylamine)-4-(2-
chloroethoxy)-5-hydroxycyclohexanecarboxylate (14)  
To a solution of 7 (24 mg, 0.088 mmol) in 2-chloroethanol 
(300 L) was added a catalytic amount of Cu(OTf)2 (6.5 mg, 
0.01 mmol) and the solution was stirred at room temperature 
under N2 atmosphere for 3 hours. The reaction was monitored by 
TLC (Hex-AcOEt, 2:1).  A solution of NH4Cl:NH3 aq (1:1) (8 
mL) was added to the reaction mixture. Then, the solution was 
extracted with AcOEt (2 x 20 mL). The organic phases were 
dried over Na2SO4 anh., and the solvent was eliminated in vacuo. 
The final product was purified by silica gel column 
chromathography using as eluent (Hexane-AcOEt, 2:1) to obtain 
13 (9 mg, 30%) and 14 (20 mg, 65%) as a transparent oil.  
Compound 13:
 
[]D  (c. 0.6, CHCl3): +36.2; 
1
H NMR (400 
MHz, CDCl3) δ (ppm) 5.58 (bs, 1H, NHBoc), 4.03-3.90 (bs, 1H, 
H2), 3.90 (dd, 1H,  J 9.6, 4.4 Hz, CH2O),  3.75 (s, 3H, OCH3), 
3.74-3.63 (m, 4H, CH2O, CH2Cl, H4), 3.33-3.26 (m, 1H, H5), 
3.00 (q, 1H, J 4.4 Hz, H1), 2.55(bs, 1H, OH), 2.41 (td, 1H, J 13.9, 
4.1 Hz, H6), 2.14 (dtd, 1H,  J 12.9, 4.4, 1.1 Hz, H3), 1.83 (ddd, 
1H, J 13.0, 10.6, 9.8 Hz, H3), 1.58 (ddd, 1H, J 14.0, 10.8, 4.6 Hz, 
H6), 1.46 (s, 9H, CH3Boc); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 
155.0 (C=O), 79.8 (C5), 71.1 (C4), 69.5 (CH2O), 52.0 (OCH3), 
47.3 (C2), 43.4 (CH2Cl), 42.7 (C1), 34.2 (C3), 28.3 (C6), 28.3 
(CH3Boc); ESI-MS for C15H26ClNO6 Calc.  M
+  
351.1
 
Exp. 374.2 
(M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 374.13385 
C15H26NO6ClNa requires 374.13409
  
Compound 14: []D  (c. 1.05, CHCl3): -3.2;
 1
H NMR (400 MHz, 
CDCl3) δ (ppm) 4.90 (bs, 1H, NHBoc) 4.23 (bs, 1H, H2), 3.88 (td, 
1H,  J 7.7, 3.3 Hz, CH2O),  3.69 (s, 3H, OCH3), 3.69-3.60 (m, 
3H, CH2O, CH2Cl, H5), 3.39 (dt, 1H,  J 9.0, 3.8 Hz, H4), 2.76 (dt, 
1H, J 9.3, 4.1 Hz, H1), 2.29 (ddd, 1H, J 13.2, 5.7, 3.9 Hz, H3), 
2.15 (td, 1H,  J 14.2, 4.3 Hz, H6), 1.85 (td, 1H, J 14.2, 9.3 Hz, 
H6), 1.55 (ddd, 1H, J 13.1, 9.1, 3.7 Hz, H3), 1.43 (s, 9H, CH3Boc); 
13
C NMR (100 MHz, CDCl3) δ (ppm) 155.0 (C=O), 79.3 (C4), 
70.2 (C5), 69.4 (CH2O), 52.0 (OCH3), 46.7 (C2), 43.4 (CH2Cl), 
42.8 (C1), 29.7 (C3), 29.0 (C6), 28.3 (CH3Boc); ESI-MS for 
C15H26ClNO6 Calc.  M
+  
351.1
 
Exp. 374.2 (M+Na)
+
; HRMS 
(ESI): (M+Na)
+
, found 374.13377 C15H26NO6ClNa requires 
374.13409 
4.9 Methyl (1S,2R,4S,5S)-2-(N-tert-butoxycarbonylamine)-4-(2-
chloroethoxy)-5-(tert-butyldimethylsilanyloxy)cyclohexane 
carboxylate  (15) 
 To a solution of 13 (130 mg, 0.37 mmol) and Imidazol (38 
mg, 0.56 mmol) in DMF (1 mL) was added TBDMS-Cl (83 mg, 
0.56 mmol) and the reaction was for 6 hours at room 
temperature. Then, the solution was diluted in CH2Cl2 (15 mL), 
washed with water ( 3 x 10 mL) and dried over Na2SO4 anh. The 
residue was purified by flash chromathography using as eluent 
(Hex-AcOEt, 9:1) to yield 15 (153 mg, 89%) as a transparent oil. 
[]D  (c. 0.65, CHCl3): +28.1; 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) 6.03 (d, 1H, J= 9.4 Hz, NHBoc), 4.26 (dd, 1H, J 8.6, 3.2 
Hz, H2), 3.94-3.89 (m, 1H, H4), 3.78-3.71 (m, 1H, CH2O), 3.69-
3.63 (m, 1H, CH2O), 3.66 (s, 3H, OCH3), 3.57 (t, 2H, J 5.5 Hz, 
CH2Cl), 3.46-3.42 (m, 1H, H5), 2.86 (td, 1H, J 12.4, 3.5 Hz, H1), 
2.14 (ddd, 1H, J 14.4, 12.4, 2.1 Hz, H6), 2.00 (td, 1H, J 14.4, 3.6 
Hz, H3), 1.79 (td, 1H, J 14.4, 3.1 Hz, H6), 1.71 (td, 1H, J 14.3, 
3.6 Hz, H3), 1.38 (s, 9H, CH3Boc), 0.92 (s, 9H, SiC(CH3)3), 0.10 
(s, 3H, SiCH3), 0.09 (s, 3H, SiCH3); 
13
C NMR (100 MHz, 
CDCl3) δ (ppm) 173.9 (C=O), 155.0 (C=O), 77.4 (C5), 69.4 
(CH2O), 68.7 (C4),  51.8 (CH3O), 46.7 (C2), 43.2 (CH2Cl), 40.6 
(C1), 32.6 (C3), 28.3 (CH3Boc), 25.7 (SiC(CH3)3), 17.8 (C6), -5.0 
(SiCH3), -5.2 (SiCH3); ESI-MS for C21H40ClNO6Si Calc.  M
+  
465.2
  
Exp. 488.4 (M+Na)
+
 & 504.3 (M+K)
+
; HRMS (ESI): 
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6 
(M+Na)
+
, found 488.22088 C21H40NO6ClSiNa requires 
488.22056 
4.10. Methyl (1S,2R,4R,5R)-2-(N-tert-butoxycarbonylamine)-4-
(2-chloroethoxy)-5-(tert-butyldimethylsilanyloxy)cyclohexane 
carboxylate  (17) 
 To a solution of 14 (360 mg, 1.03 mmol) and Imidazol (105 
mg, 1.54 mmol) in DMF (3 mL) was added TBDMS-Cl (231 mg, 
1.54 mmol) and the reaction was for 6 hours at room 
temperature. Then, the solution was diluted in CH2Cl2 (50 mL), 
washed with water (3 x 25 mL) and dried over Na2SO4 anh. The 
residue was purified by flash chromathography using as eluent 
(Hex-AcOEt, 9:1) to yield 17 (397 mg, 86%) as an transparent 
oil. []D  (c. 1.00, CHCl3): -2.6; 
 1
H NMR (400 MHz, CDCl3) δ 
(ppm) 5.46 (bs, 1H, NHBoc), 4.11 (bs, 1H, H2), 3.85 (td, 1H,  J  
10.7, 5.6 Hz, CH2O), 3.75 (dd, 1H,  J 8.8, 4.3 Hz, H5), 3.71-3.65 
(m, 1H, CH2O), 3.69 (s, 3H, OCH3), 3.61 (t, 2H, J 5.4 Hz, 
CH2Cl), 3.44-3.40 (m, 1H, H4), 2.68 (q, 1H, J 5.1 Hz, H1), 2.31 
(ddd, 1H, J 13.4, 10.0, 3.8.1 Hz, H3), 2.13-2.05 (m, 2H, 2H6), 
1.70 (td, 1H, J 13.4, 4.4 Hz, H3), 1.45 (s, 9H, CH3Boc), 0.89 (s, 
9H, SiC(CH3)3), 0.75 (s, 3H, SiCH3), 0.65 (s, 3H, SiCH3); 
13
C 
NMR (100 MHz, CDCl3) δ (ppm) 174.0 (C=O), 155.1 (C=O), 
79.2 (C4), 69.6 (CH2O), 68.8 (C5),  51.5 (CH3O), 44.8 (C2), 43.0 
(CH2Cl), 41.4 (C1), 31.0 (C6), 29.7 (C3), 29.3 (CH3Boc), 25.8 
(SiC(CH3)3), -4.8 (SiCH3), -5.1 (SiCH3); ESI-MS for 
C21H48ClNO6Si Calc.  M
+  
465.2
 
 Exp. 488.4 (M+Na)
+
; HRMS 
(ESI): (M+Na)
+
, found 488.22001 C21H40NO6ClSiNa requires 
294.22056 
4.11 Methyl (1S,2R,4S,5S)-4-(2-aminoethoxy)-2-(N-tert-
butoxycarbonylamino)-5-(tert-butyldimethylsilanyloxy) 
cyclohexancarboxylate (16)   
To a solution of 15 (225 mg, 0.49 mmol) in DMF (5 mL) were 
added NaN3 (452 mg, 6.90 mmol) and a catalytic amount of I2, 
the reaction was stirred for 48 hours at 50ºC. Then, the solution 
was diluted in CH2Cl2 (50 mL), washed with water (3 x 50 mL) 
and dried over Na2SO4 anh. The solvent was evaporated to yield 
16 (231 mg, quant.) withount further purification as an 
transparent oil. []D  (c. 0.6, CHCl3): +13.3;
 1
H NMR (400 MHz, 
CDCl3) δ (ppm) 6.06 (d, 1H, J 9.4 Hz, NHBoc), 4.31 (td, 1H, J 
12.4, 3.2 Hz, H2), 3.98-3.94 (m, 1H, H5), 3.73 (ddd, 1H, J 9.8, 
5.6, 3.2 Hz, CH2O), 3.69 (s, 3H, OCH3), 3.62 (ddd, 1H, J 10.1, 
5.7, 4.4 Hz, CH2O), 3.50-3.47 (m, 1H, H4), 3.35 (ddd, 1H, J 5.7, 
4.2, 1.6 Hz, CH2N3), 2.87 (td, 1H, J 12.5, 3.5 Hz, H1), 2.18 (ddd, 
1H, J 14.9, 12.6, 2.2 Hz, H6), 2.04 (ddd, 1H, J 14.9, 4.0, 3.1 Hz, 
H3), 1.85 (td, 1H, J 14.9, 3.7 Hz, H6), 1.74 (td, 1H, J 14.0, 3.6 
Hz, H3), 1.41 (s, 9H, CH3Boc), 0.96 (s, 9H, SiC(CH3)3), 0.14 (s, 
3H, SiCH3), 0.13 (s, 3H, SiCH3); 
13
C NMR (100 MHz, CDCl3) δ 
(ppm) 173.9 (C=O), 155.0 (C=O), 77.6 (C4), 68.7 (C5), 68.2 
(CH2O),  51.8 (CH3O), 50.9 (CH2N3), 46.7 (C2), 40.5 (C1), 32.5 
(C3), 28.3 (CH3Boc), 25.7 (SiC(CH3)3), 17.8 (C6), -5.0 (SiCH3), -
5.1 (SiCH3); ESI-MS for C21H40N4O6Si Calc.  M
+  
472.3
 
Exp. 
495.4 (M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 495.26058 
C21H40N4O6SiNa requires 495.26093 
4.12 Methyl (1S,2R,4R,5R)-4-(2-aminoethoxy)-2-(N-tert-
butoxycarbonylamine)-5-(tert-butyldimethylsilanyloxy) 
cyclohexancarboxylate (3)  
To a solution of 17 (400 mg, 0.862 mmol) in DMF (9 mL) were 
added NaN3 (448 mg, 6.90 mmol) and a catalytic amount of I2, 
the reaction was stirred for 48 hours at 50ºC. Then, the solution 
was diluted in CH2Cl2 (50 mL), washed with water (3 x 50 mL) 
and dried over Na2SO4 anh. The solvent was evaporated to yield 
3 (410 mg, quant.) without further purification as an transparent 
oil.
 
[]D  (c. 1.05, CHCl3): -10.5; 
1
H NMR (400 MHz, CDCl3) δ 
(ppm) 5.52 (bs, 1H, NHBoc), 4.10 (bs, 1H, H2), 3.87-3.70 (m, 2H, 
H5, CH2O), 3.70 (s, 3H, OCH3), 3.62 (ddd, 1H, J 12.6, 7.1, 3.3 
Hz, CH2O), 3.46-3.40 (m, 2H, H4, CH2N3), 3.36-3.30 (m, 1H, 
CH2N3), 2.70 (q, 1H, J 4.8 Hz, H1),2.31 (ddd, 1H, J 13.5, 10.5, 
3.0 Hz, H3), 2.12 (dd, 2H, J 5.1, 4.3 Hz, 2H6), 1.76 (td, 1H, J 9.3, 
4.5 Hz, H3), 1.46 (s, 9H, CH3Boc), 0.89 (s, 9H, SiC(CH3)3), 0.08 
(s, 3H, SiCH3) 0.07 (s, 3H, SiCH3); 
13
C NMR (100 MHz, CDCl3) 
δ (ppm) 174.0 (C=O), 155.2 (C=O), 79.0 (C4), 68.7 (C5), 68.1 
(CH2O),  51.4 (CH3O), 51.0 (CH2N3), 44.8 (C2), 41.3 (C1), 31.0 
(C6), 28.8 (C3), 28.4 (CH3Boc), 25.8 (SiC(CH3)3), -4.8 (SiCH3), -
5.1 (SiCH3); ESI-MS for C21H40N4O6Si Calc.  M
+  
472.3
 
Exp. 
495.4 (M+Na)
+
; HRMS (ESI): (M+Na)
+
, found 495.26055 
C21H40N4O6SiNa requires 495.26055 
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